Teva Pharmaceutical Industries (TEVA) Treasury Shares (2009 - 2026)

Teva Pharmaceutical Industries has disclosed Treasury Shares across 18 years of filings, most recently posting $4.1 billion for Q1 2026.

• Quarterly Treasury Shares changed 0.0% year-over-year to $4.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 billion (changed 0.0% YoY) and the FY2025 annual result came in at $4.1 billion, changed 0.0% from the prior year.
• Treasury Shares held at $4.1 billion in Q1 2026, from $4.1 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $107.0 million in Q4 2025 and troughed at $32.3 million in Q4 2022.
• A 5-year average of $93.4 million and a median of $106.0 million in 2022 frame the typical range for Treasury Shares.
• Biggest YoY gain for Treasury Shares was 0.0% in 2022; the steepest drop was 0.0% in 2022.
• Tracing TEVA's Treasury Shares over 5 years: stood at $4.1 billion in 2022, then changed by 0.0% to $4.1 billion in 2023, then changed by 0.0% to $4.1 billion in 2024, then changed by 0.0% to $4.1 billion in 2025, then changed by 0.0% to $4.1 billion in 2026.
• Business Quant data shows TEVA's Treasury Shares at $4.1 billion in Q1 2026, $4.1 billion in Q4 2025, and $4.1 billion in Q3 2025.